NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: Blockade by adiponectin

Sanjeev Choudhary, Sandeep Sinha, Yanhua Zhao, Srijita Banerjee, Padma Sathyanarayana, Sadeka Shahani, Vadim Sherman, Ronald Tilton, Mandeep Bajaj

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Enhanced levels of nuclear factor (NF)-κB-inducing kinase (NIK), an upstream kinase in the NF-κB pathway, have been implicated in the pathogenesis of chronic inflammation in diabetes. We investigated whether increased levels of NIK could induce skeletal muscle insulin resistance. Six obese subjects with metabolic syndrome underwent skeletal muscle biopsies before and six months after gastric bypass surgery to quantitate NIK protein levels. L6 skeletal myotubes, transfected with NIK wild-type or NIK kinase-dead dominant negative plasmids, were treated with insulin alone or with adiponectin and insulin. Effects of NIK overexpression on insulin-stimulated glucose uptake were estimated using tritiated 2-deoxyglucose uptake. NF-κB activation (EMSA), phosphatidylinositol 3 (PI3) kinase activity, and phosphorylation of inhibitor κB kinase β and serine-threonine kinase (Akt) were measured. After weight loss, skeletal muscle NIK protein was significantly reduced in association with increased plasma adiponectin and enhanced AMP kinase phosphorylation and insulin sensitivity in obese subjects. Enhanced NIK expression in cultured L6 myotubes induced a dose-dependent decrease in insulin-stimulated glucose uptake. The decrease in insulin-stimulated glucose uptake was associated with a significant decrease in PI3 kinase activity and protein kinase B/Akt phosphorylation. Overexpression of NIK kinase-dead dominant negative did not affect insulin-stimulated glucose uptake. Adiponectin treatment inhibited NIK-induced NF-κB activation and restored insulin sensitivity by restoring PI3 kinase activation and subsequent Akt phosphorylation. These results indicate that NIK induces insulin resistance and further indicate that adiponectin exerts its insulin-sensitizing effect by suppressing NIK-induced skeletal muscle inflammation. These observations suggest that NIK could be an important therapeutic target for the treatment of insulin resistance associated with inflammation in obesity and type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)3622-3627
Number of pages6
JournalEndocrinology
Volume152
Issue number10
DOIs
StatePublished - Oct 2011

Fingerprint

Adiponectin
Insulin Resistance
Skeletal Muscle
Phosphotransferases
Insulin
Phosphatidylinositol 3-Kinase
Proto-Oncogene Proteins c-akt
Phosphorylation
Glucose
Skeletal Muscle Fibers
Inflammation
Adenylate Kinase
Gastric Bypass
Protein-Serine-Threonine Kinases
Deoxyglucose
Type 2 Diabetes Mellitus
Weight Loss

ASJC Scopus subject areas

  • Endocrinology

Cite this

Choudhary, S., Sinha, S., Zhao, Y., Banerjee, S., Sathyanarayana, P., Shahani, S., ... Bajaj, M. (2011). NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: Blockade by adiponectin. Endocrinology, 152(10), 3622-3627. https://doi.org/10.1210/en.2011-1343

NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance : Blockade by adiponectin. / Choudhary, Sanjeev; Sinha, Sandeep; Zhao, Yanhua; Banerjee, Srijita; Sathyanarayana, Padma; Shahani, Sadeka; Sherman, Vadim; Tilton, Ronald; Bajaj, Mandeep.

In: Endocrinology, Vol. 152, No. 10, 10.2011, p. 3622-3627.

Research output: Contribution to journalArticle

Choudhary, S, Sinha, S, Zhao, Y, Banerjee, S, Sathyanarayana, P, Shahani, S, Sherman, V, Tilton, R & Bajaj, M 2011, 'NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: Blockade by adiponectin', Endocrinology, vol. 152, no. 10, pp. 3622-3627. https://doi.org/10.1210/en.2011-1343
Choudhary S, Sinha S, Zhao Y, Banerjee S, Sathyanarayana P, Shahani S et al. NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: Blockade by adiponectin. Endocrinology. 2011 Oct;152(10):3622-3627. https://doi.org/10.1210/en.2011-1343
Choudhary, Sanjeev ; Sinha, Sandeep ; Zhao, Yanhua ; Banerjee, Srijita ; Sathyanarayana, Padma ; Shahani, Sadeka ; Sherman, Vadim ; Tilton, Ronald ; Bajaj, Mandeep. / NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance : Blockade by adiponectin. In: Endocrinology. 2011 ; Vol. 152, No. 10. pp. 3622-3627.
@article{5059e88ddae74f6d894423bad7e53bca,
title = "NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: Blockade by adiponectin",
abstract = "Enhanced levels of nuclear factor (NF)-κB-inducing kinase (NIK), an upstream kinase in the NF-κB pathway, have been implicated in the pathogenesis of chronic inflammation in diabetes. We investigated whether increased levels of NIK could induce skeletal muscle insulin resistance. Six obese subjects with metabolic syndrome underwent skeletal muscle biopsies before and six months after gastric bypass surgery to quantitate NIK protein levels. L6 skeletal myotubes, transfected with NIK wild-type or NIK kinase-dead dominant negative plasmids, were treated with insulin alone or with adiponectin and insulin. Effects of NIK overexpression on insulin-stimulated glucose uptake were estimated using tritiated 2-deoxyglucose uptake. NF-κB activation (EMSA), phosphatidylinositol 3 (PI3) kinase activity, and phosphorylation of inhibitor κB kinase β and serine-threonine kinase (Akt) were measured. After weight loss, skeletal muscle NIK protein was significantly reduced in association with increased plasma adiponectin and enhanced AMP kinase phosphorylation and insulin sensitivity in obese subjects. Enhanced NIK expression in cultured L6 myotubes induced a dose-dependent decrease in insulin-stimulated glucose uptake. The decrease in insulin-stimulated glucose uptake was associated with a significant decrease in PI3 kinase activity and protein kinase B/Akt phosphorylation. Overexpression of NIK kinase-dead dominant negative did not affect insulin-stimulated glucose uptake. Adiponectin treatment inhibited NIK-induced NF-κB activation and restored insulin sensitivity by restoring PI3 kinase activation and subsequent Akt phosphorylation. These results indicate that NIK induces insulin resistance and further indicate that adiponectin exerts its insulin-sensitizing effect by suppressing NIK-induced skeletal muscle inflammation. These observations suggest that NIK could be an important therapeutic target for the treatment of insulin resistance associated with inflammation in obesity and type 2 diabetes.",
author = "Sanjeev Choudhary and Sandeep Sinha and Yanhua Zhao and Srijita Banerjee and Padma Sathyanarayana and Sadeka Shahani and Vadim Sherman and Ronald Tilton and Mandeep Bajaj",
year = "2011",
month = "10",
doi = "10.1210/en.2011-1343",
language = "English (US)",
volume = "152",
pages = "3622--3627",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "10",

}

TY - JOUR

T1 - NF-κB-inducing kinase (NIK) mediates skeletal muscle insulin resistance

T2 - Blockade by adiponectin

AU - Choudhary, Sanjeev

AU - Sinha, Sandeep

AU - Zhao, Yanhua

AU - Banerjee, Srijita

AU - Sathyanarayana, Padma

AU - Shahani, Sadeka

AU - Sherman, Vadim

AU - Tilton, Ronald

AU - Bajaj, Mandeep

PY - 2011/10

Y1 - 2011/10

N2 - Enhanced levels of nuclear factor (NF)-κB-inducing kinase (NIK), an upstream kinase in the NF-κB pathway, have been implicated in the pathogenesis of chronic inflammation in diabetes. We investigated whether increased levels of NIK could induce skeletal muscle insulin resistance. Six obese subjects with metabolic syndrome underwent skeletal muscle biopsies before and six months after gastric bypass surgery to quantitate NIK protein levels. L6 skeletal myotubes, transfected with NIK wild-type or NIK kinase-dead dominant negative plasmids, were treated with insulin alone or with adiponectin and insulin. Effects of NIK overexpression on insulin-stimulated glucose uptake were estimated using tritiated 2-deoxyglucose uptake. NF-κB activation (EMSA), phosphatidylinositol 3 (PI3) kinase activity, and phosphorylation of inhibitor κB kinase β and serine-threonine kinase (Akt) were measured. After weight loss, skeletal muscle NIK protein was significantly reduced in association with increased plasma adiponectin and enhanced AMP kinase phosphorylation and insulin sensitivity in obese subjects. Enhanced NIK expression in cultured L6 myotubes induced a dose-dependent decrease in insulin-stimulated glucose uptake. The decrease in insulin-stimulated glucose uptake was associated with a significant decrease in PI3 kinase activity and protein kinase B/Akt phosphorylation. Overexpression of NIK kinase-dead dominant negative did not affect insulin-stimulated glucose uptake. Adiponectin treatment inhibited NIK-induced NF-κB activation and restored insulin sensitivity by restoring PI3 kinase activation and subsequent Akt phosphorylation. These results indicate that NIK induces insulin resistance and further indicate that adiponectin exerts its insulin-sensitizing effect by suppressing NIK-induced skeletal muscle inflammation. These observations suggest that NIK could be an important therapeutic target for the treatment of insulin resistance associated with inflammation in obesity and type 2 diabetes.

AB - Enhanced levels of nuclear factor (NF)-κB-inducing kinase (NIK), an upstream kinase in the NF-κB pathway, have been implicated in the pathogenesis of chronic inflammation in diabetes. We investigated whether increased levels of NIK could induce skeletal muscle insulin resistance. Six obese subjects with metabolic syndrome underwent skeletal muscle biopsies before and six months after gastric bypass surgery to quantitate NIK protein levels. L6 skeletal myotubes, transfected with NIK wild-type or NIK kinase-dead dominant negative plasmids, were treated with insulin alone or with adiponectin and insulin. Effects of NIK overexpression on insulin-stimulated glucose uptake were estimated using tritiated 2-deoxyglucose uptake. NF-κB activation (EMSA), phosphatidylinositol 3 (PI3) kinase activity, and phosphorylation of inhibitor κB kinase β and serine-threonine kinase (Akt) were measured. After weight loss, skeletal muscle NIK protein was significantly reduced in association with increased plasma adiponectin and enhanced AMP kinase phosphorylation and insulin sensitivity in obese subjects. Enhanced NIK expression in cultured L6 myotubes induced a dose-dependent decrease in insulin-stimulated glucose uptake. The decrease in insulin-stimulated glucose uptake was associated with a significant decrease in PI3 kinase activity and protein kinase B/Akt phosphorylation. Overexpression of NIK kinase-dead dominant negative did not affect insulin-stimulated glucose uptake. Adiponectin treatment inhibited NIK-induced NF-κB activation and restored insulin sensitivity by restoring PI3 kinase activation and subsequent Akt phosphorylation. These results indicate that NIK induces insulin resistance and further indicate that adiponectin exerts its insulin-sensitizing effect by suppressing NIK-induced skeletal muscle inflammation. These observations suggest that NIK could be an important therapeutic target for the treatment of insulin resistance associated with inflammation in obesity and type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=80053154665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053154665&partnerID=8YFLogxK

U2 - 10.1210/en.2011-1343

DO - 10.1210/en.2011-1343

M3 - Article

C2 - 21846802

AN - SCOPUS:80053154665

VL - 152

SP - 3622

EP - 3627

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 10

ER -